Passage Bio, INC. (PASG) — SC 13D/A Filings
All SC 13D/A filings from Passage Bio, INC.. Browse 3 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (3)
-
Versant Venture Capital VI Amends Passage BIO Stake
— Aug 9, 2024 Risk: medium
Versant Venture Capital VI, L.P. filed an amendment (No. 3) to its Schedule 13D on August 9, 2024, regarding its holdings in Passage BIO, Inc. The filing indica -
Versant Venture Capital VI Amends Passage BIO Stake
— May 29, 2024 Risk: medium
Versant Venture Capital VI, L.P. filed an amendment (No. 2) to its Schedule 13D on May 29, 2024, regarding its holdings in Passage BIO, Inc. The filing indicate -
OrbiMed Amends Passage BIO Stake Filing
— Apr 12, 2024 Risk: medium
OrbiMed Advisors LLC, along with affiliated entities, has amended its Schedule 13D filing for Passage BIO, Inc. as of April 12, 2024. The filing indicates a cha
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX